Click to see the Elly Vaughan Interview
Global Inequities in Healthcare
A REPORT BY THE ECONOMIST INTELLIGENCE UNIT
Covid-19: the impact on healthcare expenditure
Fighting Cervical Cancer
Global action on financing cervical cancer elimination
Funding secondary prevention services in low resource settings
COVID & The Vulnerable
Elly Vaughan shares findings and insights from an EIU project sponsored by ViiV Healthcare that will be published in September called Achieving health equity: eliminating disparities by 2040. Lessons at the intersection of HIV and other STIs, mental health, and COVID-19 in the US and UK. The project examined disparities in healthcare through the lens of HIV, mental health, and covid-19.
Interviewer, Kelly Earp, PhD
Dr. Kelly Earp is a scientist and operational expert who has played a critical role in numerous high-profile programs. Kelly has worked with GHL for more than five years. She played a leading role in the onboarding of clinical trials sites for the ASH Research Collaborative contract at GHL. She has executed randomized clinical trials (RCT) and non-RCT designs in both clinical and non-clinical settings. She was critical to the development of an updated national supply chain assessment toolkit (NSCA 2.0) for the USAID contractor, Axios International. In her roles at the University of South Florida and as a scientist at Family Health International (FHI 360), Dr. Earp successfully assembled and managed cross-cultural research teams. She has worked across multiple sectors including private, academic, non-profit, and government.
Elly is an Associate in Health Policy and Clinical Evidence practice at the Economist Investigational Unit. Elly is involved in all stages of projects, from business development and project design through to execution and completion. She has experience in harnessing a range of research methodologies to answer all kinds of health policy questions with actionable solutions. Originally joining the EIU as an Information Specialist in 2011, Elly has a Masters from UCL in Library and Information Studies.
Clinical Trials Timeline Studies
The Innovation Imperative was a project in which Elly led the analysis to explore the impact of different innovative clinical trial designs on their time to recruit participants, the proportion of time recruitment represented, and links between trial design and drug launch. She also worked on multiple scorecards and index projects that benchmark how different countries perform. In particular, Elly has worked on scorecards and indexes exploring policy on non-communicable diseases in adolescents and diabetes.
Policy Decision Making
Elly and colleagues use a variety of different analytical techniques to review and formulate the best policy-led approaches to tackling the key health challenges of our time. In our project focused on Achieving health equity: eliminating disparities by 2040, we used a foresight analysis to generate scenario-based concepts that would challenge conventional approaches. This was combined with a stakeholder ecosystem analysis to enable us to identify the key actors involved. These streams of analysis combined to provide an actionable insight into what to do next and why, and how to build on what we already know.
Elly has specific expertise in emergency preparedness and response, covering infectious disease outbreaks and other types of emergencies, having worked on a number of reviews in this area for the European Centre for Disease Prevention and Control (ECDC) and Robert Koch Institute (Link), including a number of peer reviewed publications (Best practices in ranking communicable disease threats, Enablers and Barriers to Community Engagement in Public Health Emergency Preparedness, Enhancing Reporting of After Action Reviews of Public Health Emergencies to Strengthen Preparedness, Natural disasters and infectious disease in Europe: a literature review to identify cascading risk pathways). These projects have looked at managing the implementation of non-pharmaceutical interventions in response to covid-19, as well as the risk from infectious disease outbreaks and other types of emergencies, such as natural disasters.
School-Based Health Programs
The analysis by Elly and colleagues for the END Fund estimated that eliminating the most prevalent parasitic worms in Ethiopia, Kenya, Rwanda, and Zimbabwe would boost their economies by $5.1bn and increase children’s future earnings by $1.2bn (being free from infection would enable them to attend school more regularly and concentrate better). Integrated delivery with other programs – such as school-based health programs, maternal health, and HIV clinics – can further increase cost efficiency, as most costs come from treatment delivery.
Get In Touch
Elly is an Associate in Health Policy and Clinical Evidence practice at the Economist Intelligence Unit. Elly is involved in all stages of projects, from business development and project design through to execution and completion. She has experience in harnessing a range of research methodologies to answer all kinds of health policy questions with actionable solutions. Originally joining the EIU as an Information Specialist in 2011, Elly has a Masters from UCL in Library and Information Studies.